Expression of A-myb, but not c-myb and B-myb, is restricted to Burkitt's lymphoma, sIg+ B-acute lymphoblastic leukemia, and a subset of chronic lymphocytic leukemias

Blood

Volumn 87, Issue 5, 1996, Pages 1900-1911

  Golay, J ^a   Luppi, M ^b   Songia, S ^b   Palvarini, C ^b   Lombardi, L ^b   Aiello, A ^b   Delia, D ^b   Lam, K ^b   Crawford, D H ^b   Biondi, A ^b   Barbui, T ^b   Rambaldi, A ^b   Introna, M ^b  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ONCOPROTEIN; TRANSCRIPTION FACTOR;

ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BURKITT LYMPHOMA; CHRONIC LYMPHATIC LEUKEMIA; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; LEUKEMIA CELL LINE; LYMPHOCYTE TRANSFORMATION; LYMPHOMA CELL LINE; ONCOGENE; ONCOGENE C MYB; PRIORITY JOURNAL;

EID: 13344276569     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v87.5.1900.1900     Document Type: Article

References (65)

1. Nomura N, Takahashi M, Matsui M, Ishii S, Date T, Sasamoto S, Ishizaki R: Isolation of human cDN A clones of myb-related genes, A-myb and B-myb. Nucleic Acids Res 16:11075, 1988
2. Golay J, Loffarelli L, Luppi M, Castellano M, Introna M: The human A-myb protein is a strong activator of transcription. Oncogene 9:2469, 1994
3. Radke K, Beug H, Kornfeld S, Graf T: Transformation of both erythroid and myeloid cells by E26, an avian leukemia virus that contains the myb gene. Cell 31:643, 1982
4. Beug H, Leutz A, Khan P, Graf T: Ts mutants of E26 leukemia virus allow transformed myeloblasts, but not erythroblasts or fibroblasts, to differentiate at the nonpermissive temperature. Cell 39:579, 1984
5. Introna M, Luchetti M, Castellano M, Arsura M, Golay J: The myb oncogene family of transcription factors: Potent regulators of hematopoietic cell proliferation and differentiation. Semin Cancer Biol 5:113, 1993
6. Gewirtz AM, Calabretta B: A c-myb antisense oligodeoxynucleotide inhibits normal human hematopoiesis in vitro. Science 242:1303, 1988
7. Clarke MF, Kukowska Latallo JF, Westin E, Smith M, Prochownik EV: Constitutive expression of a c-myb cDNA blocks Friend murine erythroleukemia cell differentiation. Mol Cell Biol 8:884, 1988
8. Introna M, Golay J, Frampton J, Nakano T, Ness S, Graf T: Mutations in the v-myb alter the differentiation of myelomonocytic cells transformed by the oncogene. Cell 63:1287, 1990
9. Mucenski ML, McLain K, Kier AB, Swerdlow SH, Schreiner CM, Miller TA, Pietryga DW, Scott WJJ, Potter SS: A functional c-myb gene is required for normal murine fetal hepatic hematopoiesis. Cell 65:677, 1991
10. Kastan MB, Stone KD, Civin CI: Nuclear oncoprotein expression as a function of lineage, differentiation stage, and proliferative status of normal human hematopoietic cells. Blood 74:1517, 1989
11. Klempnauer K-H, Arnold H, Biedenkapp H: Activation of transcription by v-myb: Evidence for two different mechanisms. Genes Dev 3:1582, 1989
12. Ness SA, Marknell A, Graf T: The v-myb oncogene product binds to and activates the promyelocyte-specific mim-1 gene. Cell 59:1115, 1989
13. Weston K, Bishop JM: Transcriptional activation by the v-myb oncogene and its cellular progenitor c-myb. Cell 58:85, 1989
14. Biedenkapp H, Borgmeyer U, Sippel AE, Klempnauer KH: Viral myb oncogene encodes a sequence-specific DNA-binding activity. Nature 335:835, 1988
15. Lane T, Ibanez C, Garcia A, Graf T, Lipsick J: Transformation by v-myb correlates with trans-activation of gene expression. Mol Cell Biol 10:2591, 1990
16. Foos G, Grimm S, Klempnauer KH: The chicken A-myb protein is a transcriptional activator. Oncogene 9:2481, 1994
17. Reiss K, Travail S, Calabretta B, Baserga R: Growth regulated expression of B-myb in fibroblasts and hematopoietic cells. J Cell Physiol 148:338, 1991
18. Golay J, Capucci A, Arsura M, Castellano M, Rizzo V, Introna M: Expression of c-myb and B-myb, but not A-myb, correlates with proliferation in human hematopoietic cells. Blood 77:149, 1991
19. Arsura M, Introna M, Passerini F, Mantovani A, Golay J: B-myb antisense oligonucleotides inhibit proliferation of human haematopoietic cell lines. Blood 79:2708, 1992
20. Golay J, Erba E, Bernasconi S, Peri G, Introna M: The A-myb gene is highly expressed in tonsillar germinal center CD38+, CD39-, sIgM- B lymphocytes and in Burkitt's lymphoma cell lines. J Immunol 153:543, 1994
21. Trauth K, Mutschler B, Jenkins NA, Gilbert DJ, Copeland NG, Klempnauer KH: Mouse A-myb encodes a trans-activator and is expressed in mitotically active cells of the developing central nervous system, adult testis and B-lymphocytes. EMBO J 13:5994, 1994
22. MacLennan CM: Germinal centers. Annu Rev Immunol 12:117, 1994
23. Shen Ong GL, Morse HC, Potter M, Mushinski JF: Two modes of c-myb activation in virus-induced mouse myeloid tumors. Mol Cell Biol 6:380, 1986
24. Gonda TJ, Cory S, Sobieszczuk P, Holtzman D, Adams JM: Generation of altered transcripts by retroviral insertion within the c-myb gene in two murine monocytic leukemias. J Virol 61:2754, 1987
25. Nason-Burchenal K, Wolff L: Activation of c-myb is an early bone-marrow event in a murine model for acute promonocytic leukemia. Proc Natl Acad Sci USA 90:1619, 1993
26. Barletta C, Pelicci PG, Kenyon LC, Smith SD, Dalla-Favera R: Relationship between the c-myb locus and the 6q- chromosomal aberration in leukemias and lymphomas. Science 235:1064, 1986
27. Pelicci PG, Lanfrancone L, Brathwaite MD, Wolman SR, Dalla-Favera R: Amplification of the c-myb oncogene in a case of human myelogenous leukemia. Science 224:1117, 1984
28. Baer MR, Augustinos P, Kinniburgh AJ: Defective c-myc and c-myb RNA turnover in acute myeloid leukemia cells. Blood 79:1319, 1992
29. Jacobs SM, Gorse KM, Kennedy SJ, Westin EH: Characterization of the rearrangement in the c-myb promoter in the acute lymphoblastic leukemia cell line CCRF-CEM. Cancer Genet Cytogenet 75:39, 1994
30. Westin EH, Gallo RC, Arya SK, Eva A, Souza LM, Baluda MA, Aaronson SA, Wong-Staal F. Differential expression of the amv gene in human hematopoietic cells. Proc Natl Acad Sci USA 79:2194, 1982
31. Bender TP, Kuehl WM: Differential expression of the c-myb proto-oncogene marks the pre-B cell/B cell junction in murine B lymphoid tumors. J Immunol 139:3822, 1987
32. Rowe M, Rooney CM, Rickinson AB, Lenoir GM, Rupani H, Moss DJ, Stein H, Epstein MA: Distinctions between endemic and sporadic forms of Epstein Barr virus-positive Burkitt's lymphoma. Int J Cancer 35:435, 1985
33. Tweeddale ME, Lim B, Jamal N, Robinson J, Zalcberg J, Lockwood G, Minden MD, Messner HA: The presence of clonogenic cells in high grade malignant lymphoma: A prognostic factor. Blood 69:1307, 1987
34. Lombardi L, Newcomb EW, Dalla-Favera R: Pathogenesis of Burkitt's lymphoma: Expression of an activated c-myc oncogene causes the tumorigenic conversion of EBV-infected human B lymphoblasts. Cell 49:161, 1987
35. Gregory CD, Rowe M, Rickinson AD, Hardie D, Ling NR: Lymphoblastoid progression of Burkitt's lymphoma cells in vitro. A study with a panel of antibodies, in McMichael AJ (ed): Leukocyte Typing III. Oxford, UK, Oxford University Press, 1986
36. Barletta C, Druck T, LaForgia S, Calabretta B, Drabkin H, Patterson D, Croce CM, Huebner K: Chromosome locations of the MYB related genes, A-MYB and B-MYB. Cancer Res 51:3821, 1991
37. Joos S, Haluska FG, Falf MH, Henglein B, Hameister H, Croce CM, Bornkamm GW: Mapping chromosomal breakpoints of Burkitt's t(8;14) translocations far upstream of c-myc. Cancer Res 52:6547, 1992
38. Neri A, Barriga F, Knowles DM, Magrath IT, Dalla-Favera R: Different regions of the immunoglobulin heavy-chain locus are involved in chromosomal translocations in distinct pathogenetic forms of Burkitt lymphoma. Proc Natl Acad Sci USA 85:2748, 1988
39. Ma X-P, Calabretta B: DNA binding and transactivation activity of A-myb, a c-myb related gene. Cancer Res 54:6512, 1994
40. Lüscher B, Eisenman RN: mitosis-specific phosphorylation of the nuclear oncoproteins myc and myb. J Cell Biol 118:775, 1992
41. Arsura M, Luchetti M, Erba E, Golay J, Rambaldi A, Introna M: Dissociation between p93-B-myb and p75 c-myb expression during the proliferation and differentiation of human myeloid cell lines. Blood 83:778, 1994
42. Takemoto Y, Tashiro S, Handa H, Ishii S: Multiple nuclear localization signals of the B-myb gene product. FEBS Lett 350:55, 1994
43. Magrath I: The pathogenesis of Burkitt's lymphoma. Adv Cancer Res 55:134, 1990
44. Ling NR, Hardie D, Lowe J, Johnson GD, Khan M, MacLennan ICM: A phenotypic study of cells from Burkitt Lymphoma and EBV-B-lymphoblastoid lines and their relationship to cells in normal lymphoid tissues. Int J Cancer 43:112, 1989
45. Ehlin-Henriksson B, Manneborg-Sandlung A, Klein G: Expression of B-cell-specific markers in different Burkitt lymphoma subgroups. Int J Cancer 39:211, 1987
46. Inghirami G, Grignani F, Sternas L, Lombardi L, Knowles DM, Dalla-Favera R: Down regulation of LFA-1 adhesion receptors by c-myc oncogene in human B lymphoblastoid cells. Science 250:682, 1990
47. Caligiun MA, Reeds J: Immunology of acute leukemias, in Hendersen S, Lister PA (eds): Leukemia. Philadelphia, PA, Saunders, 1990, p 105
48. Dighiero G, Travade P, Chevret S, Fenaux P, Chastang C, Binet JL, The French Cooperative Group on CLL: B-cell chronic lymphocytic leukemia: Present status and future directions. Blood 78:1901, 1991
49. Matolcsy A, Inghirami G, Knowles DM: Molecular genetic demonstration of the diverse evolution of Richter's Syndrome (chronic lymphocytic leukemia and subsequent large cell lymphoma). Blood 83:1363, 1994
50. Delsol G, Laurent G, Kuhlein E, Familiades J, Rigal F, Pris J: Richter's syndrome. Evidence for the clonal origin of the two proliferations. Am J Clin Pathol 76:308, 1981
51. Bertoli LF, Kubagawa H, Borzillo GV, Mayumi M, Prchal JT, Kearney JF, Durant JR, Cooper MD: Analysis with antiidiotype antibody of a patient with chronic lymphocytic leukemia and large cell lymphoma (Richter's syndrome). Blood 70:45, 1987
52. Miyamura K, Osada H, Yamauchi T, Itoh M, Kodera Y, Suchi T, Takahashi T, Ueda R: Single clonal origin of neoplastic B cells with different immunoglobulin light chains in a patient with Richter's syndrome. Cancer 66:140, 1990
53. Chan WC, Dekmezian R: Phenotypic changes, in large cell transformation of small cell lymphoid malignancies. Cancer 57:1971, 1986
54. Schots R, Dehou MF, Jochmans K, Heirman C, De Waele M, Van Camp B, Thielemans K: Southern blot analysis in a case of Richter's syndrome. Am J Clin Pathol 95:57, 1991
55. Joshi SS, DeBoer JM, Strandjord SJ, Pirruccelo SJ, Sanger WG, Weisenburger DD, Sharp JG: Characterization of a newly established human Burkitt's lymphoma cell line, OMA-BL-1. Int J Cancer 47:643, 1991
56. Gregory CD, Tursz T, Edwards CF, Tetaud C, Talbot M, Caillou B, Rickinson AB, Lipinski M: Identification of normal B cells with a Burkitt's lymphoma (BL)-like phenotype. J Immunol 139:313, 1987
57. Liu Y-J, Joshua DE, William GT, Smith CA, Goredon J, MacLennan ICM: Mechanism of antigen driven selection in germinal centers. Nature 342:929, 1989
58. Gregory CD, Dive C, Henderson S, Smith CA, Williams GT, Gordon J, Rickinson AB: Activation of Epstein-Barr virus latent genes protects human B cells from death by apoptosis. Nature 349:612, 1991
59. Foon KA, Rai K, Gale R: CLL: New insights into biology and therapy. Ann Intern Med 113:525, 1990
60. Herzenberg LA, Stall AM, Lalor PA, Sidman C, Moore WA, Parks DR, Herzenberg LA: The Ly-1 lineage. Immunol Rev 93:81, 1986
61. Kantor A: A new nomenclature for B cells. Immunol Today 12.388, 1991
62. Shipp MA, Reinherz EL: Differential expression of nuclear proto-oncogenes in T cells triggered with mitogenic and non-mitogenic T3 and T11 activation signals. J Immunol 139:2143, 1987
63. Shapiro LH: Myb and ets proteins cooperate to transactivate an early myeloid gene. J Biol Chem 270:8763, 1995
64. Burk O, Mink S, Ringwald M, Klempnauer KH: Synergistic activation of the chicken mim-1 gene by v-myb and C/EBP transcription factors. EMBO J 12:2027, 1993
65. Sleeman JP: Xenopus A-myb is expressed during early spermatogenesis. Oncogene 8:193, 1993